Traded May 21 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Traded Apr 30, 2026 · Filed Apr 30, 2026
A Gentex director sold $112K of Gentex shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$112,247
Shares × reported transaction price
6 days after results of Apr 24, 2026, 85 days before results of Jul 24, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +2.8% | +2.4% | +0.5% |
| 30 days | +5.8% | +5.3% | +0.6% |
| 90 days | +3.9% | +2.9% | +1.0% |
Past results only. Not a forecast.
Traded May 21 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Traded May 21 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.
Traded May 21 · filed 1 day later
Compensation award — excluded from discretionary-purchase analysis.